Mutation of the PIK3CA gene as a prognostic factor in patients with colorectal cancer
Clinical Characteristics and Prognostic Values of PIK3CA Mutation in Colorectal Cancer Patients
Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer | Nature Communications
Aspirin Use Not Associated With Survival in PIK3CA-Mutant Colorectal Cancer - The ASCO Post
Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited | Cellular and Molecular Life Sciences
KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer - The Lancet Oncology
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis - The Lancet Oncology
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer | Cell Death & Disease
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer | Cell Death & Disease
Colorectal Cancer and the Targets involved in Mechanism of It- CUSABIO
PIK3CA (3q26.3) Orange + Copy Control 3 FISH Probe - Biocare Medical
PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN | Molecular Cancer | Full Text
Frontiers | PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
PIK3CA point mutation rates in TCGA cohorts. Analysis of TCGA cohorts... | Download Scientific Diagram
PIK3CA in Colorectal Cancer. - Abstract - Europe PMC
Cancer-Associated PIK3CA Mutations in Overgrowth Disorders: Trends in Molecular Medicine
Prevalence and characteristics of PIK3CA mutation in mismatch repair-deficient colorectal cancer
Cancer-Associated PIK3CA Mutations in Overgrowth Disorders: Trends in Molecular Medicine
Cancers | Free Full-Text | Deactivation of Glutaminolysis Sensitizes PIK3CA-Mutated Colorectal Cancer Cells to Aspirin-Induced Growth Inhibition
PIK3CA Biomarker | Colorectal Cancer Alliance
Molecular Detection of Colorectal Cancer | Encyclopedia MDPI
The response of PIK3CA/KRAS-mutant colorectal cancer stem-like cells to RGD-peptide FraC produced by the strawberry anemone: A promising water-soluble peptide-based inhibitor of metastasis-driver gene CXCR4, stem cell regulatory genes and self-renewal -
Knockin of mutant PIK3CA activates multiple oncogenic pathways | PNAS
Prognostic value of the PIK3CA, AKT, and PTEN mutations in oral squamous cell carcinoma: literature review
Multi-gene custom panels for the characterisation of metastatic colorectal carcinoma in clinical practice: express the role of PIK3CA mutations | Journal of Clinical Pathology
